AstraZeneca PLC (AZNN) - Total Liabilities

Latest as of December 2025: MX$65.36 Billion MXN ≈ $3.76 Billion USD

Based on the latest financial reports, AstraZeneca PLC (AZNN) has total liabilities worth MX$65.36 Billion MXN (≈ $3.76 Billion USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore AZNN net asset momentum to track the company's year-over-year net asset growth rate.

AstraZeneca PLC - Total Liabilities Trend (2014–2025)

This chart illustrates how AstraZeneca PLC's total liabilities have evolved over time, based on quarterly financial data. See AstraZeneca PLC free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.

AstraZeneca PLC Competitors by Total Liabilities

The table below lists competitors of AstraZeneca PLC ranked by their total liabilities.

Company	Country	Total Liabilities
Merck & Company Inc NYSE:MRK	USA	$82.75 Billion
Novartis AG MX:NVSN	Mexico	MX$79.61 Billion
Royal Bank of Canada TO:RY	Canada	CA$2.19 Trillion
Morgan Stanley SA:MSBR34	Brazil	R$1.25 Trillion
General Electric Company SA:GEOO34	Brazil	R$110.15 Billion
Philip Morris International Inc NYSE:PM	USA	$76.21 Billion
AstraZeneca PLC NASDAQ:AZN	USA	$66.63 Billion
LVMH Moët Hennessy - Louis Vuitton Société Européenne PA:MC	France	€74.70 Billion

Liability Composition Analysis (2014–2025)

This chart breaks down AstraZeneca PLC's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see market cap of AstraZeneca PLC.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	0.94	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	1.34	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.57	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how AstraZeneca PLC's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for AstraZeneca PLC (2014–2025)

The table below shows the annual total liabilities of AstraZeneca PLC from 2014 to 2025.

Year	Total Liabilities	Change
2025-12-31	MX$65.36 Billion ≈ $3.76 Billion	+3.47%
2024-12-31	MX$63.16 Billion ≈ $3.64 Billion	+1.95%
2023-12-31	MX$61.95 Billion ≈ $3.57 Billion	+4.25%
2022-12-31	MX$59.42 Billion ≈ $3.42 Billion	-10.07%
2021-12-31	MX$66.08 Billion ≈ $3.80 Billion	+29.33%
2020-12-31	MX$51.09 Billion ≈ $2.94 Billion	+9.21%
2019-12-31	MX$46.78 Billion ≈ $2.69 Billion	+0.37%
2018-12-31	MX$46.61 Billion ≈ $2.68 Billion	-0.22%
2017-12-31	MX$46.71 Billion ≈ $2.69 Billion	+1.86%
2016-12-31	MX$45.86 Billion ≈ $2.64 Billion	+10.37%
2015-12-31	MX$41.55 Billion ≈ $2.39 Billion	+6.67%
2014-12-31	MX$38.95 Billion ≈ $2.24 Billion	--

About AstraZeneca PLC

MX:AZNN Mexico Drug Manufacturers - General

Market Cap

$290.50 Billion

MX$5.05 Trillion MXN

Market Cap Rank

#59 Global

#3 in Mexico

Share Price

MX$1628.00

Change (1 day)

+1.25%

52-Week Range

MX$1289.81 - MX$1722.60

All Time High

MX$1751.39